Inhibition of CDK2 activity results in cell cycle arrest in human breast carcinoma cells34 and CDK9 inhibition subsequently causes the inactivation of RNAP II, resulting in cell apoptosis in multiple myeloma cells35. The gene discussed is CDK9; the disease is plasma cell myeloma.